Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase

Mimi Tamamori-Adachi, Hiromitsu Takagi, Kimio Hashimoto, Kazumichi Goto, Toshinori Hidaka, Uichi Koshimizu, Kazuhiko Yamada, Ikuko Goto, Yasuhiro Maejima, Mitsuaki Isobe, Keiichi I. Nakayama, Norio Inomata, Shigetaka Kitajima

研究成果: ジャーナルへの寄稿記事

27 引用 (Scopus)

抄録

Aims: Cyclins and other cell-cycle regulators have been used in several studies to regenerate cardiomyocytes in ischaemic heart failure. However, proliferation of cardiomyocytes induced by nuclear-targeted cyclin D1 (D1NLS) stops after one or two rounds of cell cycles due in part to accumulation of p27Kip1, an inhibitor of cyclin-dependent kinase (CDK). Thus, expression of S-phase kinase-associated protein 2 (Skp2), a negative regulator of p27Kip1, significantly enhances the effect of D1NLS and CDK4 on cardiomyocyte proliferation in vitro. Here, we examined whether Skp2 can also improve cardiomyocyte regeneration and post-ischaemic cardiac performance in vivo. Methods and results: Wistar rats underwent ischaemia/reperfusion injury by ligation of the coronary artery followed by injection of adenovirus vectors for D1NLS and CDK4 with or without Skp2. Enhanced proliferation of cardiomyocytes in the presence of Skp2 was demonstrated by increased expression of Ki67, a marker of proliferating cells (1.95% vs. 4.00%), and mitotic phosphorylated histone H3 (0.24% vs. 0.58%). Compared with rats that received only D1NLS and CDK4, expression of Skp2 improved left ventricular function as measured by the maximum and minimum rates of change in left ventricular pressure, the left ventricle end-diastolic pressure, left ventricle end-diastolic volume index, and the lung/body weight ratio. Conclusion: Expression of Skp2 enhanced the effect of D1NLS and CDK4 on the proliferation of cardiomyocytes and further contributed to improved post-ischaemic cardiac function. Skp2 might be a versatile tool to improve the effect of cyclins on post-ischaemic regeneration of cardiomyocytes in vivo.

元の言語英語
ページ(範囲)181-190
ページ数10
ジャーナルCardiovascular research
80
発行部数2
DOI
出版物ステータス出版済み - 11 1 2008

Fingerprint

S-Phase Kinase-Associated Proteins
Cyclin D1
Ligases
Ubiquitin
Cardiac Myocytes
Heart Failure
Myocardial Infarction
Cyclins
Heart Ventricles
Regeneration
Cell Cycle
Cyclin-Dependent Kinases
Ventricular Pressure
Reperfusion Injury
Left Ventricular Function
Adenoviridae
Histones
Ligation
Wistar Rats
Coronary Vessels

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

これを引用

Tamamori-Adachi, M., Takagi, H., Hashimoto, K., Goto, K., Hidaka, T., Koshimizu, U., ... Kitajima, S. (2008). Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. Cardiovascular research, 80(2), 181-190. https://doi.org/10.1093/cvr/cvn183

Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. / Tamamori-Adachi, Mimi; Takagi, Hiromitsu; Hashimoto, Kimio; Goto, Kazumichi; Hidaka, Toshinori; Koshimizu, Uichi; Yamada, Kazuhiko; Goto, Ikuko; Maejima, Yasuhiro; Isobe, Mitsuaki; Nakayama, Keiichi I.; Inomata, Norio; Kitajima, Shigetaka.

:: Cardiovascular research, 巻 80, 番号 2, 01.11.2008, p. 181-190.

研究成果: ジャーナルへの寄稿記事

Tamamori-Adachi, M, Takagi, H, Hashimoto, K, Goto, K, Hidaka, T, Koshimizu, U, Yamada, K, Goto, I, Maejima, Y, Isobe, M, Nakayama, KI, Inomata, N & Kitajima, S 2008, 'Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase', Cardiovascular research, 巻. 80, 番号 2, pp. 181-190. https://doi.org/10.1093/cvr/cvn183
Tamamori-Adachi, Mimi ; Takagi, Hiromitsu ; Hashimoto, Kimio ; Goto, Kazumichi ; Hidaka, Toshinori ; Koshimizu, Uichi ; Yamada, Kazuhiko ; Goto, Ikuko ; Maejima, Yasuhiro ; Isobe, Mitsuaki ; Nakayama, Keiichi I. ; Inomata, Norio ; Kitajima, Shigetaka. / Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. :: Cardiovascular research. 2008 ; 巻 80, 番号 2. pp. 181-190.
@article{06126950c6104cb49188cd6d520a1775,
title = "Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase",
abstract = "Aims: Cyclins and other cell-cycle regulators have been used in several studies to regenerate cardiomyocytes in ischaemic heart failure. However, proliferation of cardiomyocytes induced by nuclear-targeted cyclin D1 (D1NLS) stops after one or two rounds of cell cycles due in part to accumulation of p27Kip1, an inhibitor of cyclin-dependent kinase (CDK). Thus, expression of S-phase kinase-associated protein 2 (Skp2), a negative regulator of p27Kip1, significantly enhances the effect of D1NLS and CDK4 on cardiomyocyte proliferation in vitro. Here, we examined whether Skp2 can also improve cardiomyocyte regeneration and post-ischaemic cardiac performance in vivo. Methods and results: Wistar rats underwent ischaemia/reperfusion injury by ligation of the coronary artery followed by injection of adenovirus vectors for D1NLS and CDK4 with or without Skp2. Enhanced proliferation of cardiomyocytes in the presence of Skp2 was demonstrated by increased expression of Ki67, a marker of proliferating cells (1.95{\%} vs. 4.00{\%}), and mitotic phosphorylated histone H3 (0.24{\%} vs. 0.58{\%}). Compared with rats that received only D1NLS and CDK4, expression of Skp2 improved left ventricular function as measured by the maximum and minimum rates of change in left ventricular pressure, the left ventricle end-diastolic pressure, left ventricle end-diastolic volume index, and the lung/body weight ratio. Conclusion: Expression of Skp2 enhanced the effect of D1NLS and CDK4 on the proliferation of cardiomyocytes and further contributed to improved post-ischaemic cardiac function. Skp2 might be a versatile tool to improve the effect of cyclins on post-ischaemic regeneration of cardiomyocytes in vivo.",
author = "Mimi Tamamori-Adachi and Hiromitsu Takagi and Kimio Hashimoto and Kazumichi Goto and Toshinori Hidaka and Uichi Koshimizu and Kazuhiko Yamada and Ikuko Goto and Yasuhiro Maejima and Mitsuaki Isobe and Nakayama, {Keiichi I.} and Norio Inomata and Shigetaka Kitajima",
year = "2008",
month = "11",
day = "1",
doi = "10.1093/cvr/cvn183",
language = "English",
volume = "80",
pages = "181--190",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase

AU - Tamamori-Adachi, Mimi

AU - Takagi, Hiromitsu

AU - Hashimoto, Kimio

AU - Goto, Kazumichi

AU - Hidaka, Toshinori

AU - Koshimizu, Uichi

AU - Yamada, Kazuhiko

AU - Goto, Ikuko

AU - Maejima, Yasuhiro

AU - Isobe, Mitsuaki

AU - Nakayama, Keiichi I.

AU - Inomata, Norio

AU - Kitajima, Shigetaka

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Aims: Cyclins and other cell-cycle regulators have been used in several studies to regenerate cardiomyocytes in ischaemic heart failure. However, proliferation of cardiomyocytes induced by nuclear-targeted cyclin D1 (D1NLS) stops after one or two rounds of cell cycles due in part to accumulation of p27Kip1, an inhibitor of cyclin-dependent kinase (CDK). Thus, expression of S-phase kinase-associated protein 2 (Skp2), a negative regulator of p27Kip1, significantly enhances the effect of D1NLS and CDK4 on cardiomyocyte proliferation in vitro. Here, we examined whether Skp2 can also improve cardiomyocyte regeneration and post-ischaemic cardiac performance in vivo. Methods and results: Wistar rats underwent ischaemia/reperfusion injury by ligation of the coronary artery followed by injection of adenovirus vectors for D1NLS and CDK4 with or without Skp2. Enhanced proliferation of cardiomyocytes in the presence of Skp2 was demonstrated by increased expression of Ki67, a marker of proliferating cells (1.95% vs. 4.00%), and mitotic phosphorylated histone H3 (0.24% vs. 0.58%). Compared with rats that received only D1NLS and CDK4, expression of Skp2 improved left ventricular function as measured by the maximum and minimum rates of change in left ventricular pressure, the left ventricle end-diastolic pressure, left ventricle end-diastolic volume index, and the lung/body weight ratio. Conclusion: Expression of Skp2 enhanced the effect of D1NLS and CDK4 on the proliferation of cardiomyocytes and further contributed to improved post-ischaemic cardiac function. Skp2 might be a versatile tool to improve the effect of cyclins on post-ischaemic regeneration of cardiomyocytes in vivo.

AB - Aims: Cyclins and other cell-cycle regulators have been used in several studies to regenerate cardiomyocytes in ischaemic heart failure. However, proliferation of cardiomyocytes induced by nuclear-targeted cyclin D1 (D1NLS) stops after one or two rounds of cell cycles due in part to accumulation of p27Kip1, an inhibitor of cyclin-dependent kinase (CDK). Thus, expression of S-phase kinase-associated protein 2 (Skp2), a negative regulator of p27Kip1, significantly enhances the effect of D1NLS and CDK4 on cardiomyocyte proliferation in vitro. Here, we examined whether Skp2 can also improve cardiomyocyte regeneration and post-ischaemic cardiac performance in vivo. Methods and results: Wistar rats underwent ischaemia/reperfusion injury by ligation of the coronary artery followed by injection of adenovirus vectors for D1NLS and CDK4 with or without Skp2. Enhanced proliferation of cardiomyocytes in the presence of Skp2 was demonstrated by increased expression of Ki67, a marker of proliferating cells (1.95% vs. 4.00%), and mitotic phosphorylated histone H3 (0.24% vs. 0.58%). Compared with rats that received only D1NLS and CDK4, expression of Skp2 improved left ventricular function as measured by the maximum and minimum rates of change in left ventricular pressure, the left ventricle end-diastolic pressure, left ventricle end-diastolic volume index, and the lung/body weight ratio. Conclusion: Expression of Skp2 enhanced the effect of D1NLS and CDK4 on the proliferation of cardiomyocytes and further contributed to improved post-ischaemic cardiac function. Skp2 might be a versatile tool to improve the effect of cyclins on post-ischaemic regeneration of cardiomyocytes in vivo.

UR - http://www.scopus.com/inward/record.url?scp=54149111192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54149111192&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvn183

DO - 10.1093/cvr/cvn183

M3 - Article

C2 - 18596061

AN - SCOPUS:54149111192

VL - 80

SP - 181

EP - 190

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 2

ER -